An examination of proactive preparedness and readiness review for future enrollment in the agency’s QMM program—now in the pilot stage as an effort to incentivize pharma manufacturers to achieve a more mature state of quality culture.
William Hauck
Advertisement
Senior Associate, Shabas Solutions LLC.
Articles by William Hauck
Advertisement
Latest Updated Articles
Going Beyond Compliance: Early Adoption of FDA’s Quality Management Maturity Program—and the Practical Considerations for ExecutivesPublished: August 18th 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
From Evidence to Access: How Real-World Data Delivers for Patients
2
WHO Finalizes United States’ Withdrawal from Organization: Report
3
Pharma Companies Raise List Prices, Including 16 That Had Agreements to Lower Prices with Trump Administration: Report
4
Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase: Report
5